Pharmacological Studies of FUT-175, Nafamstat Mesilate I. Inhibition of Protease Activity in in Vitro and in Vivo Experiments
Open Access
- 1 January 1984
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 35 (3) , 203-227
- https://doi.org/10.1254/jjp.35.203
Abstract
FUT-175, 6-amidino-2-naphthyl p-guanidinobenzoate dimethanesulfonate (nafamstat mesilate), a novel synthetic protease-inhibiting agent, was studied to determine its in vitro effects against various proteases and other enzymes, as well as to determine its in vivo protease inhibitory effects. FUT-175 inhibited in an intense, specific and reversible way, the enzyme activities of trypsin, C[complement component]1.hivin.r, C1.hivin.s, thrombin, kallikrein and plasmin with IC50 [median inhibitory concentration] values of the order of 10-6 to 10-8 M. FUT-175 also inhibited complement-mediated hemolysis, including both classical and alternative pathways, sites of inhibition being on C1.hivin.r and C1.hivin.s as evidenced by the intermediate-cell technique. In animal model reactions in which the complement system is known to be involved as pathogenetic factors, e.g., Forssman shock, Forssman cutaneous vasculitis, zymosan-induced paw edema, endotoxin shock and local Shwartzman reaction, FUT-175 was highly effective in that, for example, i.v. dosing at 3 mg/kg could completely protect guinea pigs from the lethal Forssman shock. FUT-175 was also effective in trypsin-induced shock in mice, in lethality due to thrombin-thrombosis in mice and in kinin formation in the inflammatory process in rats.This publication has 35 references indexed in Scilit:
- Inhibition of alternative pathway factor D by factor B ‐related synthetic hexapeptidesEuropean Journal of Immunology, 1982
- Inhibition of Various Immunological Reactions in vivo by a New Synthetic Complement InhibitorInternational Archives of Allergy and Immunology, 1981
- Comparative effects of drugs on four paw oedema models in the ratInflammation Research, 1979
- Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement.The Journal of Experimental Medicine, 1975
- Synthetic low molecular weight inhibitors of serum kallikreinBiochemical Pharmacology, 1974
- IN VITRO STUDIES OF COMPLEMENT FUNCTION IN SERA OF C4-DEFICIENT GUINEA PIGSThe Journal of Experimental Medicine, 1971
- Irreversible enzyme inhibitors. CLXIV. Proteolytic enzymes. 14. Inhibition of guinea pig complement by meta-substituted benzamidinesJournal of Medicinal Chemistry, 1969
- INTERACTIONS OF THE COMPLEMENT SYSTEM WITH ENDOTOXIC LIPOPOLYSACCHARIDE: CONSUMPTION OF EACH OF THE SIX TERMINAL COMPLEMENT COMPONENTSThe Journal of Experimental Medicine, 1968
- PROTEIN BINDING OF PANCREATIC PROTEOLYTIC ENZYMES*Journal of Clinical Investigation, 1962
- The Determination of Enzyme Dissociation ConstantsJournal of the American Chemical Society, 1934